Clinical Trial Update: Anakinra for Inflammatory Pustular Skin Diseases [Phase 2]

View source ↗

Summary

Phase 2 trial update on anakinra for inflammatory pustular skin diseases (Sneddon-Wilkinson, Acrodermatitis Continua of Hallopeau) with completed status and res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acrodermatitis Continua of Hallopeau
• Palmoplantar Pustulosis
• Pustular Psoriasis
• Sneddon-wilkinson

Drugs mentioned

• Anakinra (anakinra)

Snippet

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Sneddon-Wilkinson, Acrodermatitis Continua of Hallopeau | Phase 2 | Status: COMPLETED | Results posted: 2021-04-30